Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675985 · ClinicalTrials.gov registry record · NA
Early Intensive Physical Therapy in Subarachnoid Hemorrhage
A NA study of Subarachnoid Hemorrhage, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02675985: Completed NA study of Subarachnoid Hemorrhage, sponsored by University of Colorado, Denver.
NCT02675985 is a NA study of Subarachnoid Hemorrhage that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 3,586-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02675985, a NA study of Subarachnoid Hemorrhage, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the safety and feasibility of early intensive physical therapy for patients diagnosed with subarachnoid hemorrhage. Intervention will begin in the neurological Intensive Care Unit (ICU) and continue for 30 days or hospital discharge.
Conditions Studied
Interventions
- OTHER Physical Therapy
Study Locations (1)
Colorado
- UCH - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08 |
| Est. Completion | 2017-11-14 |
| Phase | NA |
What the finished NCT02675985 record still lists
NCT02675985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,586-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Physical Therapy is the first listed.
NCT02675985 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02675985 about?
NCT02675985 is a clinical study titled "Early Intensive Physical Therapy in Subarachnoid Hemorrhage". This study will investigate the safety and feasibility of early intensive physical therapy for patients diagnosed with subarachnoid hemorrhage. Intervention will begin in the neurological Intensive Care Unit (ICU) and continue for 30 days or hospital discharge.
What is the current status of trial NCT02675985?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-08. Estimated completion is 2017-11-14.
What conditions does trial NCT02675985 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage.
What interventions are being tested in trial NCT02675985?
The interventions under investigation include: Physical Therapy (OTHER).
Who is sponsoring clinical trial NCT02675985?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02675985 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02675985's enrollment target sits among peer trials
30 18th of 21 higher than 3 of 21 other Subarachnoid Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Auricular VNS Following Subarachnoid Hemorrhage
RECRUITING · NA
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
-
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
RECRUITING · NA
-
Cerebral Perfusion Pressure (CPP) Management Information Feedback and Nursing
COMPLETED · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia